SENS Earnings Date: Nov 9, 2026 (Estimated) — Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is SENS's next earnings date?
Senseonics Holdings, Inc. (SENS) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.49 on revenue of $16.2M.
How did SENS do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Senseonics Holdings, Inc. posted EPS of -$0.63 versus the -$0.61 estimate, a miss of 3.3%. Revenue was $14.5M against a $13.4M estimate. The stock's 1-day post-earnings move was +36.3%.
How much does SENS stock move after earnings?
SENS beat EPS estimates in 0 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 14.4% (up or down) in the day after earnings.
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.61 | -0.63 | -3.28% | $14.5M | ❌ Miss | +36.31% | +50.10% | +86.99% |
| 2026-05-07 | Q1 2026 | -0.69 | -0.71 | -2.90% | $11.7M | ❌ Miss | -6.16% | +8.58% | +33.02% |
| 2026-03-02 | Q4 2025 | -0.43 | -0.46 | -6.98% | $14.3M | ❌ Miss | -18.07% | -24.25% | -20.05% |
| 2025-11-05 | Q3 2025 | -0.37 | -0.43 | -16.22% | $8.1M | ❌ Miss | -7.58% | -2.08% | -1.63% |
| 2025-08-06 | Q2 2025 | -0.02 | -0.02 | +0.00% | $6.6M | ➖ Inline | -4.87% | -0.90% | -5.98% |
| 2025-03-03 | Q4 2024 | -0.03 | -0.03 | +0.00% | $8.3M | ➖ Inline | -19.31% | -32.93% | -23.56% |
| 2024-11-07 | Q3 2024 | -0.03 | -0.04 | -33.33% | $4.3M | ❌ Miss | -12.53% | -19.59% | -18.06% |
| 2024-05-13 | Q1 2024 | -0.03 | -0.03 | +0.00% | $5.0M | ➖ Inline | +10.29% | +5.58% | -9.95% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q2 FY26 · $14.5M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 86.8% | $12.6M | +154.2% | $15.3M | $4.5M | $4.9M | $6.4M |
| Non-US | 13.2% | $1.9M | — | — | — | — | $1.7M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.